Literature DB >> 10980965

Helicobacter pylori infection in pediatric patients.

V Tolia1.   

Abstract

Helicobacter pylori is a gram-negative, spiral organism that colonizes the gastric mucosa and causes primary antral gastritis and peptic ulcer disease. Recent studies indicate that H. pylori infection acquired in childhood may cause gastric cancer in later life. H. pylori is present in both asymptomatic and symptomatic children as determined by various epidemiologic studies. The natural history of H. pylori infection is still an enigma. Its association with varied symptoms in children is considered controversial because it is frequently associated with nonulcerative gastritis in this age group. This article focuses on some of the newer developments addressing the epidemiology, transmission, pathophysiology, clinical presentation, and treatment of H. pylori infection in the pediatric population.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10980965     DOI: 10.1007/s11894-999-0114-3

Source DB:  PubMed          Journal:  Curr Gastroenterol Rep        ISSN: 1522-8037


  38 in total

1.  Effective 2-wk therapy for Helicobacter pylori disease in children.

Authors:  R Dohil; D M Israel; E Hassall
Journal:  Am J Gastroenterol       Date:  1997-02       Impact factor: 10.864

2.  Helicobacter pylori infection, gastric acid secretion, and infant growth.

Authors:  A Dale; J E Thomas; M K Darboe; W A Coward; M Harding; L T Weaver
Journal:  J Pediatr Gastroenterol Nutr       Date:  1998-04       Impact factor: 2.839

3.  One week treatment for Helicobacter pylori infection.

Authors:  D Walsh; N Goggin; M Rowland; M Durnin; S Moriarty; B Drumm
Journal:  Arch Dis Child       Date:  1997-04       Impact factor: 3.791

4.  The 13carbon urea breath test for the noninvasive detection of Helicobacter pylori in children: comparison with culture and determination of minimum analysis requirements.

Authors:  N Kalach; F Briet; J Raymond; P H Benhamou; P Barbet; M Bergeret; L Senouci; M Maurel; B Flourié; C Dupont
Journal:  J Pediatr Gastroenterol Nutr       Date:  1998-03       Impact factor: 2.839

5.  Helicobacter pylori reinfection rates in children after eradication therapy.

Authors:  S Kato; D Abukawa; N Furuyama; K Iinuma
Journal:  J Pediatr Gastroenterol Nutr       Date:  1998-11       Impact factor: 2.839

6.  Effect of metronidazole resistance on bacterial eradication of Helicobacter pylori in infected children.

Authors:  J Raymond; N Kalach; M Bergeret; P H Benhamou; J P Barbet; D Gendrel; C Dupont
Journal:  Antimicrob Agents Chemother       Date:  1998-06       Impact factor: 5.191

7.  Safety and efficacy of one-week triple therapy for eradicating Helicobacter pylori in children.

Authors:  S Kato; H Ritsuno; K Ohnuma; K Iinuma; T Sugiyama; M Asaka
Journal:  Helicobacter       Date:  1998-12       Impact factor: 5.753

8.  Helicobacter pylori among preschool children and their parents: evidence of parent-child transmission.

Authors:  D Rothenbacher; G Bode; G Berg; U Knayer; T Gonser; G Adler; H Brenner
Journal:  J Infect Dis       Date:  1999-02       Impact factor: 5.226

9.  Childhood protein-losing enteropathy associated with Helicobacter pylori infection.

Authors:  H A Cohen; R P Shapiro; M Frydman; I Varsano
Journal:  J Pediatr Gastroenterol Nutr       Date:  1991-08       Impact factor: 2.839

10.  One-week treatment with omeprazole, clarithromycin, and metronidazole in children with Helicobacter pylori infection.

Authors:  T H Casswall; G Alfvén; M Drapinski; M Bergström; K A Dahlström
Journal:  J Pediatr Gastroenterol Nutr       Date:  1998-10       Impact factor: 2.839

View more
  2 in total

1.  Diagnosis of Helicobacter pylori infection from antral biopsies in pediatric patients is urease test that reliable?

Authors:  S Madani; R Rabah; V Tolia
Journal:  Dig Dis Sci       Date:  2000-06       Impact factor: 3.199

2.  Treatment of Helicobacter pylori in Pediatrics.

Authors:  Samra S. Blanchard; Lara Bauman; Steven J. Czinn
Journal:  Curr Treat Options Gastroenterol       Date:  2004-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.